The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Thrombin functions as an inflammatory mediator through activation of its receptor.
Open accessAbstract
A rat model of inflammation was used to investigate the biological effects of thrombin. The thrombin-specific inhibitor Hirulog markedly attentuated the carrageenin-induced edema of the paw of the rat. Injection of thrombin into the paw also produced edema. The effect of thrombin was due to activation of its receptor; a thrombin receptor activating peptide (TRAP) reproduced the effects of thrombin in causing edema. TRAP also increased vascular permeability as demonstrated by extravasation of Evans blue and 125I-labeled serum albumin. The release of bioactive amines played an important role in mediating the TRAP-induced edema; the serotonin/histamine antagonist cryproheptadine and the histamine H2 receptor antagonist cimetidine reduced significantly the edema caused by TRAP. Treatment of rats with the mast cell degranulator 48/80 to deplete these cells of their stores of histamine and serotonin abolished completely the ability of TRAP to produce edema. Histochemical examination confirmed that TRAP treatment led to mast cell degranulation. Thus, it has been possible to demonstrate that thrombin acts as an inflammatory mediator in vivo by activating its receptor, which in turn leads to release of vasoactive amines from mast cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Di Rosa, M., Giroud, J. P., & Willoughby, D. A. (1971) · The Journal of Pathology · doi:10.1002/path.1711040103 · Cited by 1,402
Lorant, D. E., Patel, K. D., McIntyre, T. M., McEver, R. P., Prescott, S. M., & Zimmerman, G. A. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.1.223 · Cited by 576
Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin
Maraganore, J. M., Bourdon, P., Jablonski, J., Ramachandran, K. L., & Fenton, J. W. (1990) · Biochemistry · doi:10.1021/bi00482a021 · Cited by 466
Self-citationBrain, S. D., & Williams, T. J. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb11107.x · Cited by 447
PROSTAGLANDIN E2, PROSTAGLANDIN I2 AND THE VASCULAR CHANGES OF INFLAMMATION
WILLIAMS, T. J. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb07860.x · Cited by 344
Monocyte Chemotaxis: Stimulation by Specific Exosite Region in Thrombin
Bar-Shavit, R., Kahn, A., Wilner, G. D., & Fenton, J. W. (1983) · Science · doi:10.1126/science.6836310 · Cited by 323
Scarborough, R. M., Naughton, M. A., Teng, W., Hung, D. T., Rose, J., Vu, T. K., Wheaton, V. I., Turck, C. W., & Coughlin, S. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42184-9 · Cited by 286
Sugama, Y., Tiruppathi, C., offakidevi, K., Andersen, T. T., Fenton, J. W., & Malik, A. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.4.935 · Cited by 286
Structure of the hirugen and hirulog 1 complexes of α-thrombin
Skrzypczak-Jankun, E. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)80132-e · Cited by 261
Sciacca, F. L., Colotta, F., Sironi, M., Luini, W., & Mantovani, A. (1993) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-2952-1_30 · Cited by 205
Thrombin‐induced chemotaxis and aggregation of neutrophils
Bizios, R., Lai, L., Fenton, J. W., et al. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280318 · Cited by 202
Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo.
Gaboury, J. P., Johnston, B., Niu, X. F., & Kubes, P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.804 · Cited by 163
TOOTHILL, V. J., van MOURIK, J. A., Niewenhuis, H. K., Metzelaar, M. J., & Pearson, J. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.1.283 · Cited by 152
Garcia, J. G. N., Patterson, C. E., Bahler, C., et al. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560313 · Cited by 116
Maling, H. M., Webster, M. E., Williams, M. A., Saul, W. F., & Anderson, W. C. (1974) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29991-8 · Cited by 116
Thrombin and factor Xa enhance the production of interleukin-1.
Jones, A., & Geczy, C. L. (1990) · PubMed Central · Cited by 112
Thrombin-induced degranulation of cultured bone marrow-derived mast cells.
Razin, E., & Marx, G. S. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.6.3282 · Cited by 101
A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production.
Grandaliano, G., Valente, A. J., & Abboud, H. E. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1737 · Cited by 100
Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor
Chao, B. H., Kalkunte, S., Maraganore, J. M., et al. (1992) · Biochemistry · doi:10.1021/bi00142a001 · Cited by 99
Self-citationThrombin-Mediated Increase in Vascular Endothelial Permeability
Malik, A. B., & Fenton, J. W. (1992) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002425 · Cited by 96
The role of leukocytes in the activation of blood coagulation.
Rl, E., & Fr, R. (1992) · PubMed · Cited by 77
Coller, B. S., Ward, P. E., Ceruso, M., et al. (1992) · Biochemistry · doi:10.1021/bi00162a007 · Cited by 61
Principles of Cellular and Molecular Immunology
Austyn, J. M., & WOOD, K. (1994) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)90079-5 · Cited by 53
The response to thrombin of human neutrophils: Evidence for two novel receptors
Jenkins, A. L., Howells, G. L., Scott, E., Bonniec, B. L., Curtis, M. A., & Stone, S. R. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.9.3059 · Cited by 51
Self-citationPharmacological characterization of polycation‐induced rat hind‐paw oedema
Antunes, E., Mariano, M., Cirino, G., Levi, S., & Nucci, G. D. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14193.x · Cited by 41
Self-citationNew Antithrombotic Strategies for Resistant Thrombotic Processes
Harker, L. A. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb03960.x · Cited by 21
Hirudin C-Terminal Fragments lnhibit Thrombin Induced Neutrophil Chemotaxis
Rowand, J. K., Marucha, P., & Berliner, L. J. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648433 · Cited by 6
Cited by
Thrombin signalling and protease-activated receptors
Coughlin, S. R. (2000) · Nature · doi:10.1038/35025229 · Cited by 2,482
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
COUGHLIN, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01377.x · Cited by 1,035
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
Déry, O., Corvera, C. U., Steinhoff, M., & Bunnett, N. W. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.6.c1429 · Cited by 779
Mollnes, T. E., Brekke, O., Fung, M. S. C., Fure, H., Christiansen, D., Bergseth, G., Videm, V., Lappegård, K. T., Köhl, J., & Lambris, J. D. (2002) · PubMed · doi:10.1182/blood.v100.5.1869.h81702001869_1869_1877 · Cited by 455
Protease-activated receptors in inflammation, neuronal signaling and pain
Vergnolle, N., Wallace, J. L., Bunnett, N. W., & Hollenberg, M. D. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01634-5 · Cited by 369
Metadata
- Authors
- Cirino, G., Cicala, C., Bucci, M. R., Sorrentino, L., Maraganore, J. M., & Stone, S. R.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-03-01
- Volume
- 183
- Issue
- 3
- Pages
- 821-827
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2166270090
- Cited by
- 254
- References
- 28
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.